Submitted by Anonymous (not verified) on 28 January 2026 - 16:25
Human medicines European public assessment report (EPAR): Biktarvy, bictegravir,emtricitabine,tenofovir alafenamide, Date of authorisation: 21/06/2018, Revision: 19, Status: Authorised
Source: